Molecular pathogenesis of ovarian clear cell carcinoma

被引：31

作者：

Gounaris, Ioannis ^{[1
]}

Brenton, James D. ^{[1
]}

机构：

[1] Canc Res UK Cambridge Inst, Cambridge CB2 0RE, England

来源：

FUTURE ONCOLOGY | 2015年 / 11卷 / 09期

关键词：

ARID1A; endometriosis; genetically engineered mouse models; glycogen; HNF1B; ovarian clear; PIK3CA cell cancer; IDENTIFIES FREQUENT MUTATION; ARID1A PROTEIN EXPRESSION; SWI/SNF-RELATED COMPLEXES; HYPOXIA-INDUCIBLE FACTOR; REMODELING GENE ARID1A; ENDOMETRIAL CANCER; THERAPEUTIC TARGET; GLYCOGEN-SYNTHESIS; TUMOR-SUPPRESSOR; PTEN EXPRESSION;

D O I：

10.2217/fon.15.45

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Ovarian clear cell carcinoma is a distinct subtype of epithelial ovarian cancer, characterized by an association with endometriosis, glycogen accumulation and resistance to chemotherapy. Key driver events, including ARID1A mutations and HNF1B overexpression, have been recently identified and their functional characterization is ongoing. Additionally, the role of glycogen in promoting the malignant phenotype is coming under scrutiny. Appreciation of the notion that ovarian clear cell carcinoma is essentially an ectopic uterine cancer will hopefully lead to improved animal models of the disease, in turn paving the way for effective treatments.

引用

页码：1389 / 1405

页数：17

共 50 条

[1] Molecular portraits of clear cell ovarian and endometrial carcinoma with comparison to clear cell renal cell carcinoma
Ackroyd, Sarah A.
Arguello, David
Ramos, Pilar
Mahdi, Haider
ElNaggar, Adam
Winer, Ira
Holloway, Rob
Krivak, Thomas
Jones, Nathaniel
Turner, Valerie Galvan
Herzog, Thomas
Chu, Christina
Brown, Jubilee
Mantia-Smaldone, Gina
GYNECOLOGIC ONCOLOGY, 2023, 169 : 164 - 171
[2] Molecular portraits of clear cell ovarian and endometrial carcinoma with comparison to clear cell renal cell carcinoma
Mantia-Smaldone, G. M.
Arguello, D.
Mahdi, H.
ElNaggar, A. C.
Winer, I.
Holloway, R. W.
Krivak, T. C.
Jones, N. L.
Galvan-Turner, V.
Herzog, T. J.
Chu, C.
Brown, J.
GYNECOLOGIC ONCOLOGY, 2019, 154 : 175 - 175
[3] Molecular profiling of clear cell ovarian carcinoma.
Friedlander, Michael
Russell, Kenneth
Millis, Sherri Z.
Gatalica, Zoran
Voss, Andreas
JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
[4] Ovarian Clear Cell Carcinoma: Genomic Characterization, Pathogenesis and Targeted Therapy
Xie, Yunkai
Kong, Weimin
Luo, Dan
Chen, Shuning
Zhao, Xiaoling
Zhang, He
ANTICANCER RESEARCH, 2023, 43 (08) : 3401 - 3410
[5] Updates of Pathogenesis, Diagnostic and Therapeutic Perspectives for Ovarian Clear Cell Carcinoma
Zhu, Chenchen
Xu, Zhihao
Zhang, Tianjiao
Qian, Lili
Xiao, Weihua
Wei, Haiming
Jin, Tengchuan
Zhou, Ying
JOURNAL OF CANCER, 2021, 12 (08): : 2295 - 2316
[6] Ovarian Clear Cell Carcinoma: From Morphology to Molecular Biology
Improta, Giuseppina
Pettinato, Angela
Hogdall, Estrid
Santeusanio, Giuseppe
Vatrano, Simona
Fraggetta, Filippo
Zannoni, Gian Franco
APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2019, 27 (09) : 631 - 636
[7] Identification of LEFTY as a molecular marker for ovarian clear cell carcinoma
Akiya, Masashi
Yamazaki, Masaaki
Matsumoto, Toshihide
Kawashima, Yusuke
Oguri, Yasuko
Kajita, Sabine
Kijima, Daiki
Chiba, Risako
Yokoi, Ako
Takahashi, Hiroyuki
Kodera, Yoshio
Saegusa, Makoto
ONCOTARGET, 2017, 8 (38) : 63646 - 63664
[8] Molecular characterization of a panel of ovarian clear cell carcinoma (OCCC) cell lines
Huang, R.
Ye, J.
Kuay, K. T.
Tan, T. Z.
Heong, V.
Tan, D. S.
ANNALS OF ONCOLOGY, 2017, 28
[9] New perspectives on molecular targeted therapy in ovarian clear cell carcinoma
D S P Tan
R E Miller
S B Kaye
British Journal of Cancer, 2013, 108 : 1553 - 1559
[10] New perspectives on molecular targeted therapy in ovarian clear cell carcinoma
Tan, D. S. P.
Miller, R. E.
Kaye, S. B.
BRITISH JOURNAL OF CANCER, 2013, 108 (08) : 1553 - 1559

← 1 2 3 4 5 →